Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1090
Trial Sponsor
Clinical Trial Start Date
January 27, 2020
0Primary Completion Date
October 23, 2020
0Study Completion Date
October 23, 2020
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Retrospective0
Participating Facility
Official Name
An Assessment of the Safety and Performance of the MLX® Medial Lateral and XLX ACR® Expandable Lumbar Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Thoracic and/or Lumbar Spine0
Last Updated
August 24, 2021
0Study summary
The objective of this study is to evaluate the safety and performance of thoracic and/or lumbar spine surgery using the MLX and XLX ACR interbody implants as measured by reported complications, radiographic outcomes, and clinical patient outcomes. This study is being undertaken to identify possible residual risks and to clarify mid- to long-term clinical performance that may affect the benefit/risk ratios of the MLX and XLX ACR interbody implants.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
